🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
PCOS is a common endocrinopathy affecting 5-10% of women in their reproduct...
Status
Unknown
Location
Bioroma
Start Date
2014-03
Trial ID
NCT02084940
Treatments Being Tested
The aim of this study is to compare the hormonal, metabolic and clinical ef...
Status
Completed
Location
Beni-suef university Hospital
Start Date
2024-08-01
Trial ID
NCT05965908
Treatments Being Tested
Objective: To investigate the potential benefit of adding Thymoquinone to M...
Status
Completed
Location
Saudi German Hospital
Start Date
2019-02-01
Trial ID
NCT04852510
Treatments Being Tested
Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder that is fre...
Status
Recruiting
Location
Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University
Start Date
2025-02-01
Trial ID
NCT06896981
Treatments Being Tested
The aim of the study is to assess the association between the quality of li...
Status
Completed
Location
CHU de Lille Hôpital Jeanne de Flandre
Start Date
2023-07-04
Trial ID
NCT05982236
Treatments Being Tested
Insulin-resistance plays an important role in polycystic ovary syndrome (PC...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT00948402
Treatments Being Tested
OBJECTIVES: 1. Analysis of DNA methyl transferases (DNMT1, DNMT3A and DNMT...
Status
Not Yet Recruiting
Location
Dr. Shraddha Ramchandani
Start Date
2023-11-05
Trial ID
NCT06102629
Treatments Being Tested
The overall objective of this study is to determine whether serum BPA and/o...
Status
Completed
Location
Obstretrics, Gynecology and Reproductive Science, RUH
Start Date
2012-03
Trial ID
NCT02272439
The most common endocrine condition in reproductive women is polycystic ova...
Status
Completed
Location
İrem Şenyuva
Start Date
2022-06-13
Trial ID
NCT05418595
This study has two phases: 1. In phase 1 of the study (8 weeks),the effect...
Status
Completed
Location
Kvinneklinikken, Rikshospitalet-Radiumhospitalet HF
Start Date
2008-10
Trial ID
NCT00779571
Treatments Being Tested